- Home
- GEVO vs ORGO Comparison
GEVO vs ORGO Comparison
Compare GEVO & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GEVO
- ORGO
- Stock Information
- Founded
- GEVO 2005
- ORGO 1985
- Country
- GEVO United States
- ORGO United States
- Employees
- GEVO N/A
- ORGO N/A
- Industry
- GEVO Major Chemicals
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- GEVO Industrials
- ORGO Health Care
- Exchange
- GEVO Nasdaq
- ORGO Nasdaq
- Market Cap
- GEVO 498.2M
- ORGO 539.1M
- IPO Year
- GEVO 2011
- ORGO N/A
- Fundamental
- Price
- GEVO $1.91
- ORGO $5.98
- Analyst Decision
- GEVO Buy
- ORGO Buy
- Analyst Count
- GEVO 2
- ORGO 3
- Target Price
- GEVO $8.13
- ORGO $7.33
- AVG Volume (30 Days)
- GEVO 4.3M
- ORGO 2.8M
- Earning Date
- GEVO 11-10-2025
- ORGO 11-06-2025
- Dividend Yield
- GEVO N/A
- ORGO N/A
- EPS Growth
- GEVO N/A
- ORGO N/A
- EPS
- GEVO N/A
- ORGO N/A
- Revenue
- GEVO $120,932,000.00
- ORGO $465,218,000.00
- Revenue This Year
- GEVO $909.99
- ORGO $2.51
- Revenue Next Year
- GEVO $11.14
- ORGO $25.45
- P/E Ratio
- GEVO N/A
- ORGO N/A
- Revenue Growth
- GEVO 675.75
- ORGO 2.24
- 52 Week Low
- GEVO $0.92
- ORGO $2.61
- 52 Week High
- GEVO $2.98
- ORGO $7.08
- Technical
- Relative Strength Index (RSI)
- GEVO 36.43
- ORGO 69.04
- Support Level
- GEVO $1.83
- ORGO $5.91
- Resistance Level
- GEVO $2.27
- ORGO $7.08
- Average True Range (ATR)
- GEVO 0.14
- ORGO 0.43
- MACD
- GEVO -0.05
- ORGO 0.20
- Stochastic Oscillator
- GEVO 13.89
- ORGO 66.73
About GEVO Gevo Inc.
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.